Sigma-Aldrich signs exclusive distribution agreement with Roche
Provides researchers with global access to Roche biochemical reagents
Sigma-Aldrich has agreed, in an exclusive deal, to distribute Roche's Biochemical Reagents product portfolio, which includes kits and enzymes for cellular analysis, proteomics and conventional PCR (polymerase chain reaction) applications.
Eric Green, Executive Vice President and President, Sigma-Aldrich Research, said the addition of these life science tools 'supports our strategy to augment our portfolio with products that accelerate customer scientific research programmes'.
Transfer of the Roche portfolio to Sigma-Aldrich will take place during 2015. In the interim, these products will continue to be available through existing Roche channels.